Tag: Canada Biosimilars Naming

The Time is Right for Canada to Incorporate a Naming Convention for Biologics and Biosimilars into its Emerging ePrescribing Infrastructure

By Pooja Babbrah, Senior Consultant In January 2017, the Food and Drug Administration (FDA) released the Final Rule for Biosimilar Naming. In this final rule, the FDA spelled out the …